Behavioral Outcome Measures for the Assessment of Sensorimotor Function in Animal Models of Movement Disorders

Broida, 1982, Strain-typical patterns of pregnancy-induced nestbuilding in mice: Maternal and experiential influences, Physiol. Behav., 29, 53, 10.1016/0031-9384(82)90380-8 Chang, 1999, Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions, Neuroscience, 88, 617, 10.1016/S0306-4522(98)00217-6 Chartier-Harlin, 2004, Alpha-synuclein locus duplication as a cause of familial Parkinson's disease, Lancet, 364, 1167, 10.1016/S0140-6736(04)17103-1 Chen, 2005, Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice, J. Biol. Chem., 280, 21418, 10.1074/jbc.M413955200 Cohen, 1974, The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents, J. Biol. Chem., 249, 2447, 10.1016/S0021-9258(19)42751-8 Connor, 1999, Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat, Gene Ther., 6, 1936, 10.1038/sj.gt.3301033 Crawley, 2000 Fleming, 2004, Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein, J. Neurosci., 24, 9434, 10.1523/JNEUROSCI.3080-04.2004 Fleming, 2004, Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone, Exp. Neurol., 187, 418, 10.1016/j.expneurol.2004.01.023 Fleming, 2005, An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: Antiparkinson effects of sinemet and protective effects of methylphenidate, Behav. Brain Res., 156, 201, 10.1016/j.bbr.2004.05.024 Fleming, 2006, Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein, Neuroscience, 142, 1245, 10.1016/j.neuroscience.2006.07.005 Goldberg, 2003, Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons, J. Biol. Chem., 278, 43628, 10.1074/jbc.M308947200 Heikkila, 1971, Inhibition of biogenic amine uptake by hydrogen peroxide: A mechanism for toxic effects of 6-hydroxydopamine, Science, 172, 1257, 10.1126/science.172.3989.1257 Heikkila, 1973, 6-Hydroxydopamine: Evidence for superoxide radical as an oxidative intermediate, Science, 181, 456, 10.1126/science.181.4098.456 Hofele, 2001, Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility, Exp. Neurol., 168, 116, 10.1006/exnr.2000.7588 Hwang, 2003, Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice, Brain Res. Mol. Brain Res., 114, 123, 10.1016/S0169-328X(03)00162-1 Hwang, 2005, 3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: Behavioral characterization of a novel genetic model of Parkinson's disease, J. Neurosci., 25, 2132, 10.1523/JNEUROSCI.3718-04.2005 Kostrzewa, 1974, Pharmacological actions of 6-hydroxydopamine, Pharmacol. Rev., 26, 199 Kozlowski, 2000, Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections, Exp. Neurol., 166, 1, 10.1006/exnr.2000.7463 Kruger, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet., 18, 106, 10.1038/ng0298-106 LeVere, 1988, Neural system imbalances and the consequences of large brain injuries, 1 Lindner, 1996, Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms, Exp. Neurol., 132, 62, 10.1016/0014-4886(95)90059-4 Lu, 2009, BAC mice expressing a truncated mutant parkin exhibit progressive motor deficits and late-onset dopaminergic neuron degeneration, J. Neurosci., 29, 1962, 10.1523/JNEUROSCI.5351-08.2009 Luo, 2002, Subthalamic GAD gene therapy in a Parkinson's disease rat model, Science, 298, 425, 10.1126/science.1074549 Lynch, 1980, Response to divergent selection for nesting behavior in Mus musculus, Genetics, 96, 757, 10.1093/genetics/96.3.757 Olsson, 1995, Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test, J. Neurosci., 15, 3863, 10.1523/JNEUROSCI.15-05-03863.1995 Page, 2009, A gelsolin amyloidosis mouse exhibiting an age-associated decline in proteostasis triggers sporadic inclusion body myositis (sIBM), PNAS., 106, 11125, 10.1073/pnas.0811753106 Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Reliene, 2008, Effects of antioxidants on cancer prevention and neuromotor deficits in ATM deficient mice, Food Chem. Toxicol., 46, 1371, 10.1016/j.fct.2007.08.028 Rockenstein, 2002, Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters, J. Neurosci. Res., 68, 568, 10.1002/jnr.10231 Schallert, 1988, ‘Disengage’ sensorimotor deficit following apparent recovery from unilateral dopamine depletion, Behav. Brain Res., 30, 15, 10.1016/0166-4328(88)90003-4 Schallert, 2000, Intervention strategies for degeneration of dopamine neurons in parkinsonism: Optimizing behavioral assessment of outcome Schallert, 1985, Neurotransmitter-selective brain lesions, 343 Schallert, 1978, Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats, Science, 199, 1461, 10.1126/science.564552 Schallert, 1982, Tactile extinction: Distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage, Pharmacol. Biochem. Behav., 16, 455, 10.1016/0091-3057(82)90452-X Schallert, 1983, Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum, Pharmacol. Biochem. Behav., 18, 753, 10.1016/0091-3057(83)90019-9 Schallert, 1992, A clinically relevant unilateral rat model of parkinsonian akinesia, J. Neural. Trans. Plasticity, 3, 332, 10.1155/NP.1992.332 Schallert, 2000, CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury, Neuropharmacology, 39, 777, 10.1016/S0028-3908(00)00005-8 Schallert, 2002, Disentangling multiple types of recovery from brain injury, 201 Sedelis, 2001, Behavioral phenotyping of the MPTP mouse model of Parkinson's disease, Behav. Brain Res., 125, 109, 10.1016/S0166-4328(01)00309-6 Singleton, 2003, alpha-Synuclein locus triplication causes Parkinson's disease, Science, 302, 841, 10.1126/science.1090278 Szczypka, 2001, Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice, Neuron, 30, 819, 10.1016/S0896-6273(01)00319-1 Tillerson, 2001, Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine, J. Neurosci., 21, 4427, 10.1523/JNEUROSCI.21-12-04427.2001 Tillerson, 2002, Forced nonuse in unilateral parkinsonian rats exacerbates injury, J. Neurosci., 22, 6790, 10.1523/JNEUROSCI.22-15-06790.2002 Tillerson, 2002, Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1 methyl-4-phenyl 1,2,3,6-tetrahydropyridine, Exp. Neurol., 178, 80, 10.1006/exnr.2002.8021 Ungerstedt, 1968, 6-Hydroxy-dopamine induced degeneration of central monoamine neurons, Eur. J. Pharmacol., 5, 107, 10.1016/0014-2999(68)90164-7 Ungerstedt, 1971, Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system, Act. Physiol. Scand. Suppl., 367, 95, 10.1111/j.1365-201X.1971.tb11001.x Upchurch, 1983, A behavior analysis of the offspring of “haloperidol-sensitive” and “haloperidol-resistant” gerbils, Behav. Neural. Biol., 39, 221, 10.1016/S0163-1047(83)90876-2 Whishaw, 2000, Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat, Neuropharmacology, 39, 788, 10.1016/S0028-3908(99)00259-2 Yang, 2002, Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat, Exp. Neurol., 177, 50, 10.1006/exnr.2002.7989